HomeTRAW • NASDAQ
add
Traws Pharma Inc
Previous close
$2.63
Day range
$2.51 - $2.65
Year range
$0.97 - $19.44
Market cap
18.90M USD
Avg Volume
447.63K
P/E ratio
0.09
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.06M | -52.81% |
Net income | -3.96M | 53.25% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.04M | 52.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.42M | 18.67% |
Total assets | 12.44M | 39.25% |
Total liabilities | 7.90M | -28.00% |
Total equity | 4.54M | — |
Shares outstanding | 7.99M | — |
Price to book | 4.11 | — |
Return on assets | -72.24% | — |
Return on capital | -158.31% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.96M | 53.25% |
Cash from operations | -4.01M | 65.05% |
Cash from investing | -2.58M | — |
Cash from financing | -62.00K | — |
Net change in cash | -6.66M | 41.96% |
Free cash flow | -5.35M | 35.38% |
About
Founded
1998
Website
Employees
7